IRIS
CIVES, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.023
EU - Europa 523
AS - Asia 385
SA - Sud America 7
AF - Africa 4
OC - Oceania 3
Totale 3.945
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.014
CN - Cina 211
SE - Svezia 208
IT - Italia 125
SG - Singapore 124
GB - Regno Unito 50
FI - Finlandia 27
DE - Germania 26
VN - Vietnam 23
FR - Francia 21
BE - Belgio 20
UA - Ucraina 16
IN - India 12
IE - Irlanda 10
CA - Canada 9
AT - Austria 5
BR - Brasile 5
LT - Lituania 4
HK - Hong Kong 3
NL - Olanda 3
TR - Turchia 3
AR - Argentina 2
HU - Ungheria 2
MA - Marocco 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BD - Bangladesh 1
EE - Estonia 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
MK - Macedonia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 3.945
Salva come PNG Salva come JPEG
Città #
Fairfield 497
Woodbridge 388
Ashburn 258
Houston 226
Seattle 215
Chandler 206
Cambridge 201
Wilmington 184
Nyköping 183
Ann Arbor 121
Singapore 103
Beijing 75
Lawrence 63
Jacksonville 60
Roxbury 58
Nanjing 39
Des Moines 35
Inglewood 27
Dong Ket 23
Redwood City 21
Bari 18
Brussels 18
New York 18
San Diego 18
Paris 17
Santa Clara 15
Princeton 14
Helsinki 13
London 13
Rome 13
Los Angeles 12
Brooklyn 11
Dublin 10
Shenyang 10
Dearborn 9
Nanchang 9
Boardman 8
Changsha 7
Munich 7
Pune 7
Vibo Valentia 7
Hebei 6
Jiaxing 6
Taranto 5
Tianjin 5
Toronto 5
Bologna 4
Kilburn 4
Milan 4
Acton 3
Andria 3
Guangzhou 3
Haaksbergen 3
Hounslow 3
Indiana 3
Linden 3
Norwalk 3
Ottawa 3
Rahway 3
Shanghai 3
Somerville 3
Washington 3
Zhengzhou 3
Ankara 2
Auckland 2
Buenos Aires 2
Buffalo 2
Cagliari 2
Casablanca 2
Catania 2
Dallas 2
Florennes 2
Hefei 2
Hong Kong 2
Johannesburg 2
Manchester 2
Mangalore 2
Modugno 2
Muscat 2
Napoli 2
Ningbo 2
Norfolk 2
Ome 2
Palermo 2
Pearland 2
Prescot 2
Rochester 2
Saint Paul 2
San Francisco 2
San Mateo 2
Sannicandro Garganico 2
Turin 2
Verona 2
Vienna 2
Weston 2
Xi'an 2
Augusta 1
Barletta 1
Budapest 1
Calgary 1
Totale 3.388
Salva come PNG Salva come JPEG
Nome #
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors 144
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 114
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 111
Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe 107
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations 102
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition 102
New insights into the molecular pathogenesis of langerhans cell histiocytosis 101
Osteotropism of neuroendocrine tumors: Role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro 100
NETs: Organ-related epigenetic derangements and potential clinical applications 97
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. 97
Lenalidomide in multiple myeloma: current experimental and clinical data 95
Gastroenteropancreatic Neuroendocrine Tumors 94
Erdheim-Chester disease: A systematic review. 93
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 93
Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors 92
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications 90
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. 86
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 81
Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors 80
Analysis of the immune landscape of small bowel neuroendocrine tumors 77
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 77
The management of refractory carcinoid syndrome: challenges and opportunities ahead 76
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 76
Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials 75
The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors 75
Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition 74
Cell fusion in myeloma marrow microenvironment: role in tumor progression 72
Radionuclide Therapy for Neuroendocrine Tumors 72
Modified staging classification for pancreatic neuroendocrine tumors on the basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems 72
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours 71
SNPs in predicting clinical efficacy and toxicity of chemotherapy: Walking through the quicksand 69
Local treatment for focal progression in metastatic neuroendocrine tumors 68
Treatment strategies for metastatic neuroendocrine tumors of the gastrointestinal tract. 67
A phase II study of axitinib in advanced neuroendocrine tumors 65
Novel Lenalidomide-based combinations for treatment of multiple myeloma 63
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 62
Therapy for locoregional disease: pancreas 60
Local treatment for focal progression in metastatic neuroendocrine tumors 59
Analysis of Postoperative Recurrence in Stage I-III Midgut Neuroendocrine Tumors 58
Management of NETs in the Precision Medicine Era 55
Higher frequency of isolated PMS2 loss in colorectal tumors in Colombian population: preliminary results 55
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 53
Cerebellar ataxia and exercise intolerance in Erdheim-Chester disease 53
Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice 48
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors 48
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 46
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors 40
Lanreotide dopo octreotide LAR nel pNET in progressione: descrizione di un caso 39
An update on gastroenteropancreatic neuroendocrine tumors 38
1101MO Development of CAR T-cells for future treatment of NETs 36
Neuroendocrine tumors 35
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors 34
EPB41L5 is Associated with the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors 32
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives 32
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 32
Novel immunotherapy strategies for treatment of neuroendocrine neoplasms 31
A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms 30
Sensitivity and Specificity of the NETest: A Validation Study 28
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 26
The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability 26
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When KI-67 is ≥10%? 24
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment 23
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours 23
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications 21
An update on Merkel cell carcinoma 17
An Immunohistochemical Score as Predictor of the Bone Metastasis Risk in Patients with NETs 16
Adamantinoma-like Ewing sarcoma of the salivary glands: a case report and systematic literature review 13
Non-Melanoma Skin Cancers: Biological and Clinical Features 8
The impact of COVID-19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients 4
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 4
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 4
Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience 3
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database 2
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort 2
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM) 2
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives 2
Is NETTER-2 a practice-changing trial? 2
In Defense of Neuroendocrine Tumor Trials 1
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study 1
Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France 1
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives 1
Totale 4.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020665 0 0 0 0 99 65 93 107 123 70 82 26
2020/2021815 34 47 33 61 176 87 68 88 33 93 42 53
2021/2022438 41 19 3 10 17 49 14 18 38 36 69 124
2022/2023624 90 108 46 31 37 90 19 87 79 2 17 18
2023/2024310 17 55 14 38 35 63 18 11 5 13 4 37
2024/2025337 48 27 125 81 56 0 0 0 0 0 0 0
Totale 4.258